Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (NASDAQ:HKPD) — Market Cap & Net Worth
Market Cap & Net Worth: Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD)
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (NASDAQ:HKPD) has a market capitalization of $5.01 Million ($5.01 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28671 globally and #5870 in its home market, demonstrating a -7.54% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's stock price $0.12 by its total outstanding shares 42167457 (42.17 Million). Also see HKPD current and non-current assets for a full breakdown of the balance sheet.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Market Cap History: 2025 to 2026
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's market capitalization history from 2025 to 2026. Data shows change from $34.76 Million to $5.16 Million (-84.63% CAGR). Also see cash flow conversion of Hong Kong Pharma Digital Technology Hold for how efficiently the company converts equity into cash flow.
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check HKPD stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.38x
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's market cap is 0.38 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $34.76 Million | $20.31 Million | -$27.06K | 1.71x | N/A |
| 2026 | $5.16 Million | $13.43 Million | -$1.14 Million | 0.38x | N/A |
Competitor Companies of HKPD by Market Capitalization
Companies near Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares in the global market cap rankings as of September 18, 2026. Review how tangible is Hong Kong Pharma Digital Technology Hold's equity to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #249 globally with a market cap of $101.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #542 globally with a market cap of $50.53 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #642 globally with a market cap of $43.01 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1221 globally with a market cap of $21.15 Billion USD ( AU$29.90 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #249 | McKesson Corporation | NYSE:MCK | $101.38 Billion | $887.29 |
| #542 | Cencora Inc. | NYSE:COR | $50.53 Billion | $318.50 |
| #642 | Cardinal Health Inc | NYSE:CAH | $43.01 Billion | $232.54 |
| #1221 | Sigma Healthcare Ltd | AU:SIG | $21.15 Billion | AU$2.59 |
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Historical Marketcap From 2025 to 2026
Between 2025 and today, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's market cap moved from $34.76 Million to $ 5.16 Million, with a yearly change of -84.63%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $5.16 Million | -85.16% |
| 2025 | $34.76 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $5.01 Million USD |
| MoneyControl | $5.01 Million USD |
| MarketWatch | $5.01 Million USD |
| marketcap.company | $5.01 Million USD |
| Reuters | $5.01 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over-the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers customs clearance, drugs enlisting, warehouse, and other logistics services. In addition, it provides valu… Read more